07:15 AM EDT, 07/31/2026 (MT Newswires) -- Moderna ( MRNA ) reported a Q2 net loss Friday of $1.97 per diluted share, narrowing from a loss of $2.13 a year earlier.

Analysts polled by FactSet expected a loss of $2.01.

Revenue for the quarter ended June 30 was $145 million, up from $142 million a year earlier.

Analysts surveyed by FactSet expected $102.9 million.

For 2026, the company said it continues to target 10% revenue growth year over year.

Shares of the company were down 4.2% in Friday's premarket activity.